NPR News: The FDA limits the use of some monoclonal antibodies treatments

The FDA limits the use of some monoclonal antibodies treatments
The Food and Drug Administration is curbing the use of two out of three monoclonal antibody treatments because new data shows they aren't effective against the omicron variant.

Read more on NPR
Science - January 27, 2022 at 12:28AM - The FDA limits the use of some monoclonal antibodies treatments